Latest flood news: Coralville Lake down to 700.34 feet | Dubuque Street partially reopened (More info)
Research
Main Page Content
Research Feature Block
University of Iowa researchers report that a new drug holds promise for those with age-related macular degeneration (shown in this image by the darkened splotch in the center), which is the leading cause of vision loss and blindness in older Americans. Image courtesy of Vinit Mahajan, Department of Ophthalmology. | By Richard C. Lewis | 10:05 AM
By Richard C. Lewis
10:05 AM
University of Iowa ophthalmologists have tested a new drug to treat age-related macular degeneration in older patients. The researchers report that half of the eyes treated responded to the new drug, Eylea, with reduced fluid in the eyes, while one in three had improved vision after six months. Results appear in the American Journal of Ophthalmology.
